John Greenspan, whose dental and oral health research has led to major contributions to HIV research and care, is the recipient of the 2010 American Association for Dental Research Distinguished Scientist Award.
Senator Arlen Specter visited UCSF last week talking about health care reform -- the topic of today’s nationally televised summit in Washington DC.
Media Coverage
UCSF Medical Center CEO profiled in hospital magazine
Mission Bay Capital, LLC, has added a new limited partner to its first venture fund, bolstering the fund’s ability to invest in promising bioscience companies emerging from the University of California.
Media Coverage
AP story on decline in primary care quotes UCSF physician
Gary Schlimgen, director of pension and retirement programs at the University of California Office of the President, answers questions about the restart of contributions to the UC Retirement Plan. <a href="http://www.universityofcalifornia.edu/news/article/22856">Read more on the UC website</a>.
UCSF Chancellor Sue Desmond-Hellmann, MD, MPH, today named Jeffrey Bluestone as executive vice chancellor and provost, pending approval by the UC Regents.
Kimbery Topp, chair of the Department of Physical Therapy and Rehabilitation Science, has been named a fellow of the American Association of Anatomists.
Media Coverage
Regional stories quote UCSF expert on health effects of 3-D glasses
Walter S. Newman, a leading San Francisco businessman, philanthropist, and community leader, has joined the Board of Directors of NCIRE-The Veterans Health Research Institute.
UCSF has launched a family-friendly web portal and is conducting a survey on family needs with the goal of increasing the availability and access of family programs, services and events.
People with symptoms of depression in middle age have a significantly greater risk in old age of being physically disabled or unable to carry out tasks of daily living, according to a study led by researchers at the San Francisco VA Medical Center and the University of California, San Francisco.
UCSF nephrologist Flavio Vincenti, MD, is the lead author of a paper in the March 2010 issue of the <i>American Journal of Transplantation</i> that reports results from a Phase III clinical trial for a new drug that selectively blocks immune suppression for kidney transplants. The drug, belatacept, is given to kidney-transplant recipients to prevent the immune system from rejecting the new organ. Vincenti and his co-investigators found that belatacept may be as effective as the commonly used anti-rejection drug cyclosporine, but with fewer side effects and superior kidney function after 12 months.
UCSF Chancellor Sue Desmond-Hellmann told House Speaker Nancy Pelosi federal economic stimulus funds will help University scientists conduct “biomedical research that literally will change the world.”
A UCSF team, led by bioethicist Bernard Lo, MD, recommends that the National Institutes of Health ethics guidelines for embryonic stem cell research be modified to better protect the rights of individuals donating egg or sperm to patients undergoing in vitro fertilization.
Media Coverage
SF Examiner cover story focuses on UCSF, Mission Bay biotech
UCSF has signed a partnership agreement with Genentech, Inc., a wholly owned member of the Roche Group, to discover and develop drug candidates for neurodegenerative diseases.
Two UCSF scientists have been selected for the American Academy of Neurology’s prestigious Potamkin Prize, for their “outstanding achievements” in research on dementias.
UCSF Chancellor Sue Desmond-Hellmann today released a video message to the campus community explaining the need to focus on the University’s <em>advancing health worldwide mission™</em> to adjust to new fiscal realities.
UCSF is sponsoring a one-day symposium for the Bay Area research community to bring awareness to the problem of how certain foods can cause an addictive-like state in the brain and are a hidden cause behind the nation's obesity epidemic.